,

Emma Verheye1,2,3, Daliya Kancheva1,3, Hatice Satilmis2

  • 1Laboratory of Dendritic Cell Biology and Cancer Immunotherapy, VIB Center for Inflammation Research, Brussels, Belgium.

PubMed
概括

复发性多发性髓瘤 (MM) 需要了解瘤免疫微环境 (TME). 这项研究揭示了动态的TME变化,并测试了免疫增强的抗CD40疗法,显示了新的MM治疗的潜力.